Tatva Chintan Pharma Chem Ltd
NSE:TATVA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Tatva Chintan Pharma Chem Ltd
Net Income (Common)
Tatva Chintan Pharma Chem Ltd
Net Income (Common) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Tatva Chintan Pharma Chem Ltd
NSE:TATVA
|
Net Income (Common)
₹57.1m
|
CAGR 3-Years
-61%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
N/A
|
|
|
Navin Fluorine International Ltd
NSE:NAVINFLUOR
|
Net Income (Common)
₹5.5B
|
CAGR 3-Years
20%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
|
Aarti Industries Ltd
NSE:AARTIIND
|
Net Income (Common)
₹3.8B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
Asian Paints Ltd
NSE:ASIANPAINT
|
Net Income (Common)
₹38.5B
|
CAGR 3-Years
1%
|
CAGR 5-Years
7%
|
CAGR 10-Years
9%
|
|
|
Anupam Rasayan India Ltd
NSE:ANURAS
|
Net Income (Common)
₹933.5m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
Gujarat Fluorochemicals Ltd
NSE:FLUOROCHEM
|
Net Income (Common)
₹5.5B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
|
Tatva Chintan Pharma Chem Ltd
Glance View
Tatva Chintan Pharma Chem Ltd. is a chemicals manufacturing company. The company is headquartered in Vadodara, Gujarat. The company went IPO on 2021-07-29. The firm is engaged in the manufacturing of verity of chemicals include structure directing agents (SDAs), phase transfer catalysts (PTCs), electrolyte salts for capacitor batteries, and pharmaceutical and agrochemical intermediates, and other specialty chemicals (PASC). Its SDAs are quarternary salts, which helps in the formation of channels and pores during the synthesis of zeolites. Its PTCs are used to facilitate the migration of a reactant from one phase into another phase where the reaction occurs in a heterogeneous multi-phase system. The firm operates two manufacturing facilities situated at Ankleshwar and Dahej in Bharuch, Gujarat, India. The firm is focused on serving various customers across various industries, including the automotive, petroleum, pharmaceutical, agro chemicals, paints and coatings, dyes and pigments, personal care and flavors and fragrances industries.
See Also
What is Tatva Chintan Pharma Chem Ltd's Net Income (Common)?
Net Income (Common)
57.1m
INR
Based on the financial report for Mar 31, 2025, Tatva Chintan Pharma Chem Ltd's Net Income (Common) amounts to 57.1m INR.
What is Tatva Chintan Pharma Chem Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-31%
Over the last year, the Net Income (Common) growth was -81%. The average annual Net Income (Common) growth rates for Tatva Chintan Pharma Chem Ltd have been -61% over the past three years , -31% over the past five years .
